Your browser doesn't support javascript.
loading
Bendamustine and rituximab is well-tolerated and efficient in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma in elderly: A single center observational study.
Kotchetkov, Rouslan; Drennan, Ian R; Susman, David; DiMaria, Erica; Gerard, Lauren; Nay, Derek; Prica, Anca.
Afiliación
  • Kotchetkov R; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Center, Barrie, Ontario, Canada.
  • Drennan IR; Department of Family and Community Medicine, Temerity Faculty of Medicine, Sunnybrook Research Institute, Sunnybrook Health Science Center, University of Toronto, Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canad
  • Susman D; Western University, London, Ontario, Canada.
  • DiMaria E; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Center, Barrie, Ontario, Canada.
  • Gerard L; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Center, Barrie, Ontario, Canada.
  • Nay D; Simcoe Muskoka Regional Cancer Program, Royal Victoria Regional Health Center, Barrie, Ontario, Canada.
  • Prica A; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, Ontario, Canada.
Int J Cancer ; 152(9): 1884-1893, 2023 05 01.
Article en En | MEDLINE | ID: mdl-36545885
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Linfoma de Células del Manto / Neutropenia Febril Tipo de estudio: Observational_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Linfoma de Células del Manto / Neutropenia Febril Tipo de estudio: Observational_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Canadá